期刊
EUROPEAN RESPIRATORY JOURNAL
卷 29, 期 1, 页码 185-209出版社
EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/09031936.00046906
关键词
cardiopulmonary exercise testing; evaluation of interventions; exercise testing; prognosis; walking tests
Evidence-based recommendations on the clinical use of cardiopulmonary exercise testing (CPET) in lung and heart disease are presented, with reference to the assessment of exercise intolerance, prognostic assessment and the evaluation of therapeutic interventions (e.g. drugs, supplemental oxygen, exercise training). A commonly used grading system for recommendations in evidence-based guidelines was applied, with the grade of recommendation ranging from A, the highest, to D, the lowest. For symptom-limited incremental exercise, CPET indices, such as peak O-2 uptake (V'O-2), V'O-2 at lactate threshold, the slope of the ventilation-CO2 output relationship and the presence of arterial O-2 desaturation, have all been shown to have power in prognostic evaluation. In addition, for assessment of interventions, the tolerable duration of symptom-limited high-intensity constant-load exercise often provides greater sensitivity to discriminate change than the classical incremental test. Field-testing paradigms (e.g. timed and shuttle walking tests) also prove valuable. In turn, these considerations allow the resolution of practical questions that often confront the clinician, such as: 1) When should an evaluation of exercise intolerance be sought?; 2) Which particular form of test should be asked for?; and 3) What cluster of variables should be selected when evaluating prognosis for a particular disease or the effect of a particular intervention?
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据